Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by AlwaysL8on Mar 30, 2017 12:00pm
84 Views
Post# 26052572

RE:RBC seller of ADK

RE:RBC seller of ADKInteresting mission you have found Whippet. I'm curious about what is considered a reasonable position by a larger player.
If this is an institutional move out (one investor) and it is being bought by retail (many small investors) I wonder how the volitility of the sp will be effected in the short term. As an example, it is much more difficult to divest 10 mil share when the sp doubles, than 100,000, so I guess we could expect more profit taking following NR's? 
Anyone into Fibonacci numbers?
Although keep in mind that ADK was pretty generous with stock and warrent bonus during financing last year, could be some of that paper hitting the market. I don't remember the numbers off the top of my head, but I thought total was well in excess of 1 mil shares. That was all offered between .05 and .10? at the most, so any easy gain even at todays price.
Bullboard Posts